CB
CBSC.US CB Scientific Inc
- Market cap
- USD 5.97M
- P/E
- -
- P/B
- 275.45x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is CBSC.US undervalued?
Graham numberThe Graham number of CB Scientific Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CB Scientific Inc fundamental analysis
No fundamental analysis for CB Scientific Inc yet.
CB Scientific Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CB Scientific Inc
Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Cardiac Biotech Solutions Inc. in May 2025. The company is based in Las Vegas, Nevad…
Full company profileCB Scientific Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CB Scientific Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 33.0K | 36.6K | 58.7K | 122K | 32.4K | 75.6K | 82.4K | 135K | 41.4K | 153K | 161K |
| Gross Profit | -194K | -378K | 14.8K | -598K | 22.6K | -73.7K | 40.2K | 135K | 41.4K | - | - |
| Operating Income | -370K | -481K | -62.6K | -999K | -2.94M | -1.87M | -2.10M | -1.60M | -1.33M | -1.16M | -467K |
| EBITDA | -369K | -1.13M | -59.5K | -999K | -3.98M | -4.80M | -2.10M | -1.62M | -1.69M | -1.16M | -467K |
| Net Income | -386K | -1.13M | -62.6K | -999K | -4.33M | -6.34M | -2.11M | -1.63M | -1.68M | -896K | -549K |
| EPS | -0.01 | -0.02 | 0.00 | -0.02 | -0.06 | -0.07 | -0.02 | -0.01 | -0.01 | -0.01 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 67.6K | 60.6K | 36.0K | 109K | 312K | 654K | 305K | 300K | 167K | 494K | 505K |
| Total Liabilities | 586K | 1.27M | 1.07M | 2.08M | 502K | 165K | 682K | 943K | 2.12M | 2.79M | 2.73M |
| Shareholders' Equity | -518K | -1.21M | -1.03M | -1.97M | -190K | 489K | -377K | -643K | -1.96M | -2.29M | -2.22M |
| Cash & Short-term Investments | 12.5K | 4.67K | 7.60K | 15.0K | 18.7K | 427K | 136K | 126K | 50.0K | 3.86K | 2.07K |
| Total Debt | 246K | 514K | 357K | 1.80M | 389K | 43.8K | 100K | 20.9K | 263K | 538K | 528K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -62.5K | -769K | -109K | -683K | -663K | -786K | -1.19M | -1.25M | - | -637K | -767K |
| Capital Expenditure | 535.00 | 6.35K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -63.0K | -775K | -109K | -683K | -663K | -786K | -1.19M | -1.25M | - | -637K | -767K |
| Ratios | |||||||||||
| ROE | - | - | - | - | - | -1,296.6% | - | - | - | - | - |
| ROA | -570.6% | -1,868.3% | -173.9% | -920.4% | -1,387.8% | -969.8% | -691.0% | -542.8% | -1,003.8% | -181.3% | -108.6% |
| Net Profit Margin | -1,171.5% | -3,090.3% | -106.6% | -819.7% | -13,341.4% | -8,391.9% | -2,556.4% | -1,207.1% | -4,059.9% | -586.6% | -341.6% |
| Debt to Equity | - | - | - | - | - | 0.09x | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CB Scientific Inc dividends
CB Scientific Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:75 on Feb 16, 2016.
Who owns CB Scientific Inc
Ownership data of CB Scientific Inc is not available yet.
CB Scientific Inc company profile
- Company name
- CB Scientific Inc
- Ticker
- CBSC.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 5
- Fiscal year end
- March
- Address
- 10845 Griffith Peak Drive, Las Vegas, NV, United States, 89135
- Phone
- 888-225-0870
- Website
- cardiacbiotech.com
About CB Scientific Inc
Cardiac Biotech Solutions Inc., through its subsidiaries, provides ambulatory non-invasive cardiac monitoring products and services in the United States and internationally. It offers My-Cardia devices, interactive cloud-based acquisition software, and smartphone apps for patients at risk of abnormal heart rhythms. The company was formerly known as CB Scientific, Inc. and changed its name to Cardiac Biotech Solutions Inc. in May 2025. The company is based in Las Vegas, Nevada.
CB Scientific Inc management
2- Mr. Charles K. Martin IIIPresident, CEO & Director · born 1957
- Mr. William Griffin Thomas CPACFO & Treasurer · born 1976